ACAD
33.275
-0.405
-1.202%
AEMD
4.85
-0.04
-0.8200%
APRI
0.345
+0.001
+0.3203%
ARNA
1.765
-0.005
-0.282%
ATEC
8.87
-0.11
-1.22%
CNAT
2.046
-0.014
-0.680%
CRXM
0.215
+0.019
+9.4332%
CYTX
2.05
+0.03
+1.49%
DXCM
88.54
-1.2
-1.34%
GNMK
11.47
-0.22
-1.88%
HALO
12.27
-0.14
-1.13%
ILMN
179.97
-1.01
-0.56%
INNV
0.261
+0.002
+0.759%
INO
9.43
-0.11
-1.15%
ISCO
1.85
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
101.56
-0.88
-0.86%
LPTN
3.46
-0.02
-0.5718%
MBVX
4.1
+0.02
+0.49%
MEIP
1.75
+0.01
+0.57%
MNOV
7.451
-0.159
-2.0933%
MRTX
6.78
+0.06
+0.89%
MSTX
0.102
-0.005
-4.4214%
NBIX
50.81
-0.61
-1.19%
NUVA
66.97
-0.34
-0.51%
ONCS
1.722
+0.012
+0.702%
ONVO
3.84
-0.02
-0.52%
OREX
3.31
+0.02
+0.61%
OTIC
17.2
+0.13
+0.76%
QDEL
21.83
-0.08
-0.37%
RCPT
231.96
0.00
0.00%
RGLS
3.39
-0.06
-1.74%
RMD
65.375
+0.635
+0.981%
SPHS
3.04
-0.04
-1.30%
SRNE
7.82
-0.04
-0.51%
TROV
4.45
-0.04
-0.89%
VICL
3.14
+0.02
+0.64%
VOLC
18
0.00
0.00%
ZGNX
10.89
-0.32
-2.85%
ACAD
33.275
-0.405
-1.202%
AEMD
4.85
-0.04
-0.8200%
APRI
0.345
+0.001
+0.3203%
ARNA
1.765
-0.005
-0.282%
ATEC
8.87
-0.11
-1.22%
CNAT
2.046
-0.014
-0.680%
CRXM
0.215
+0.019
+9.4332%
CYTX
2.05
+0.03
+1.49%
DXCM
88.54
-1.2
-1.34%
GNMK
11.47
-0.22
-1.88%
HALO
12.27
-0.14
-1.13%
ILMN
179.97
-1.01
-0.56%
INNV
0.261
+0.002
+0.759%
INO
9.43
-0.11
-1.15%
ISCO
1.85
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
101.56
-0.88
-0.86%
LPTN
3.46
-0.02
-0.5718%
MBVX
4.1
+0.02
+0.49%
MEIP
1.75
+0.01
+0.57%
MNOV
7.451
-0.159
-2.0933%
MRTX
6.78
+0.06
+0.89%
MSTX
0.102
-0.005
-4.4214%
NBIX
50.81
-0.61
-1.19%
NUVA
66.97
-0.34
-0.51%
ONCS
1.722
+0.012
+0.702%
ONVO
3.84
-0.02
-0.52%
OREX
3.31
+0.02
+0.61%
OTIC
17.2
+0.13
+0.76%
QDEL
21.83
-0.08
-0.37%
RCPT
231.96
0.00
0.00%
RGLS
3.39
-0.06
-1.74%
RMD
65.375
+0.635
+0.981%
SPHS
3.04
-0.04
-1.30%
SRNE
7.82
-0.04
-0.51%
TROV
4.45
-0.04
-0.89%
VICL
3.14
+0.02
+0.64%
VOLC
18
0.00
0.00%
ZGNX
10.89
-0.32
-2.85%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …